Reset filters
7 January 2025

Pulmonary hypertension (PH) affects patients at all stages of life, but there are important aspects that differentiate pediatric from adult disease. The pediatric task force at the 7th World Symposium on Pulmonary Hypertension (WSPH) recently highlighted our latest understanding of these differences, including considerations relating to PH definition, classification, treatment, and prognostication.

Pulmonary Circulation
24 December 2024

This study aimed to explore the potential causal link between genetic predisposition to various connective tissue diseases (CTDs), namely systemic lupus erythematosus (SLE), Sjögren's syndrome (SS), polymyositis (PM), dermatomyositis (DM), systemic sclerosis (SSc), mixed connective tissue disease (MCTD), and rheumatoid arthritis (RA), and the incidence of pulmonary arterial hypertension (PAH) utilizing Mendelian randomization (MR). 

Pulmonary Circulation
23 December 2024

The 7th International Leh Symposium on “Molecular Mechanisms and Therapeutics of Hypoxic Lung” from August 4 to 9, 2024, organized at the Mahabodhi International Meditation Centre in Saboo, Leh, Ladakh, India, ensured the participation of a galaxy of national and international researchers, who explored the complex clinico-physiological processes associated with high-altitude adaptive and maladaptive mechanisms.

Pulmonary Circulation